Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04129801
Other study ID # 01038912.6.0000.0068
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 5, 2017
Est. completion date May 8, 2019

Study information

Verified date October 2019
Source University of Sao Paulo General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Excessive fat mass (FM) contributes to changes in the strength and endurance of skeletal muscles. Mid-thigh muscle mass is approximately 2.5 times that of fat mass, but individuals who are obese have increased intra- (fat within muscle cells) and intermuscular fat (fat between muscle cells), establishing a negative influence on strength generation capacity and functional independence. The functional capacity of a skeletal muscle can be assessed based on the muscle's ability to produce strength. The relevance of this study is to identify/analyze the changes in segmental body composition (BC) which might better determine the association between fat free mass (FFM) of the lower limbs and maximum voluntary contraction (MVC), 36 months after bariatric surgery. This study was elaborated and will be performed at the Clinical Hospital in the Medical School of the University of Sao Paulo (HCFMUSP). The patients involved will receive the Informed Consent Form. The sample, consists of 155 adults selected at the ambulatory of the Bariatric and Metabolic Surgery Unit of the Department of Gastroenterology of HCFMUSP in the periods: preoperative, 6 and 36 months after surgery. Patients of both sexes, above 18 years of age, will undergo bariatric surgery performed at the institution. Adult patients over 60 years old, undergoing revision surgery and other surgical techniques will be excluded. Anthropometric variables will be obtained on the same day as the evaluation of BC by trained evaluators. The BC will be measured by In Body 230. BMI (kg/m2) shall be determined by dividing body weight (kg) by height (m) squared. Evaluation of Body Composition and Muscle Strength will be held between 8:00 am and 10:00 am in the Laboratory of Exercise and Movement Studies at the Institute of Orthopedics and Traumatology of FMUSP. BC measurements as FM (% and kg), FFM (% and kg), will be obtained by the indirect noninvasive method of electrical bioimpedance. The dynamometer will be used to evaluate muscle strength extension (Ext) and flexion (Flex) MVC torques for both legs will be carried. The MVC assessed variables should be absolute Ext and Flex torques (Nm), Ext and Flex torques relative to the body weight (Nm/Bw) and Ext and Flex torques relative to FFM (Nm/FFM).


Description:

Anthropometric Assessment Anthropometric variables will be obtained on the same day as the evaluation of BC by trained evaluators. The body weight (kg) will be measured by In Body 230, 2.0, (Biospace Seoul, Korea). The patient should be in the orthostatic position, facing the display, in the center of the scale, barefoot, in light clothes. The height measurement (m) will be performed in a stadiometer coupled to the scale W 300, Class III, with a maximum capacity of 2m. The patient will be kept with his back to the meter, with the feet united, in an erect position, looking at horizon and arms extended to the side of the body. The reading will be made in the nearest centimeter when the horizontal rod of the vertical bar of the stature scale rests against the individual's head. BMI (kg/m2) will be determined by dividing body weight (kg) by height (m) squared.

Bioimpedance Body composition will be determined by bioelectrical impedance analysis (BIA) under constant conditions (with subjects appropriately hydrated and at the same time of day).The body composition analyzer (InBody230, Biospace Co., Gangnam-gu, Seoul, South Korea) was a segmental impedance device that uses a tetrapolar 8-point tactile electrode system, and the measured weight range was 10 to 250 kg. Impedance measurements were performed by utilizing 2 different frequencies (20 and 100 kHz) at each segment (the right arm, left arm, trunk, right leg, and left leg). The participant will be positioned in orthostatic position on a platform with lower electrodes for the feet and two brackets (the upper electrodes) gripped on hands. Data output was calculated in percentages (%) and included FM, FFM, trunk FFM, and appendicular FFM (the sum of the FFM values for the right arm, left arm, right leg, and left leg).

Isokinetic dynamometer The muscular strength evaluation will be performed on the isokinetic dynamometer, Biodex ® Multi-joint System 3 (Biodex Medical Systems Inc, Shirley, New York, USA). The dynamometer is calibrated thirty minutes before the start of the tests.

Participants are positioned for evaluation in the concentric / concentric mode of knee joint extension and flexion movements. Individuals remain seated with their hip at 90º of flexion, affixed to the chair with chest X-belts, a strap around the pelvic girdle, a strap over the distal third of the thigh and one at the distal third of the assessed leg, way to free the movements of the ankle.

All participants are instructed to perform four movements with submaximal force to familiarize themselves with the equipment. The test is performed first on the dominant limb and later on the non-dominant limb. The assessed limb is positioned with the lateral femoral condyle (axis of the knee joint movement) aligned to the mechanical axis of the dynamometer. The member that is not being evaluated will be aligned with the other member. The volunteers are instructed to perform two sets of 4 uninterrupted repetitions of knee extension and flexion with interval of 60 seconds. Throughout the period of the test, standardized and constant verbal encouragement is performed to obtain as much force as possible during contractions.

The tests are performed with concentric movements of flexion and extension of the knee, starting from 90º of flexion and reaching 20º of extension, with correction of the force of gravity.

The angular velocity used will be 60 degrees per second (60º / s).

The variables that will be obtained through the evaluation of muscular strength are:

Torque Peak (Nm): is the maximum force reached in each of the repetitions in which the test was performed. The peak torque represents the largest muscle contraction in the arc of movement and corresponds to the highest point of the force x distance curve.

Peak torque relative to body weight (Nm / kg): maximum force corrected for body weight, the result being expressed in percent newton-kilogram.


Recruitment information / eligibility

Status Completed
Enrollment 132
Est. completion date May 8, 2019
Est. primary completion date June 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Body mass index (BMI) between 40 and 60 kg/m2.

Exclusion Criteria:

- Functional disability

- Treatment with steroid medication for any reason.

- Use of artificial devices such as an orthosis or a prosthesis.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isokinetic Dynamometer
Participants then executed two series of four uninterrupted repetitions of Ext and Flex of both legs, first with the dominant member and subsequently with the non-dominant member, at an angular velocity of 60o/s, with a 60-second interval between series.
Bioimpedance
Bioimpedance The BC measurements as FM (% and kg), FFM (% and kg), will be obtained by the indirect noninvasive method of electrical bioimpedance (BIA) 230, 2.0, (Biospace Seoul, Korea). Those evaluated will be standing and positioned on the platform electrodes, barefoot and with their arms extended with their hands on the two supports (electrodes).

Locations

Country Name City State
Brazil Hospital das Clinicas da Faculdade de Medicina da USP São Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital

Country where clinical trial is conducted

Brazil, 

References & Publications (29)

Anandacoomarasamy A, Fransen M, March L. Obesity and the musculoskeletal system. Curr Opin Rheumatol. 2009 Jan;21(1):71-7. Review. — View Citation

Brown M, Sinacore DR, Host HH. The relationship of strength to function in the older adult. J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:55-9. — View Citation

Calmels PM, Nellen M, van der Borne I, Jourdin P, Minaire P. Concentric and eccentric isokinetic assessment of flexor-extensor torque ratios at the hip, knee, and ankle in a sample population of healthy subjects. Arch Phys Med Rehabil. 1997 Nov;78(11):1224-30. — View Citation

Capodaglio P, Vismara L, Menegoni F, Baccalaro G, Galli M, Grugni G. Strength characterization of knee flexor and extensor muscles in Prader-Willi and obese patients. BMC Musculoskelet Disord. 2009 May 6;10:47. doi: 10.1186/1471-2474-10-47. — View Citation

De Ste Croix M, Deighan M, Armstrong N. Assessment and interpretation of isokinetic muscle strength during growth and maturation. Sports Med. 2003;33(10):727-43. Review. — View Citation

Gadducci AV, de Cleva R, de Faria Santarém GC, Silva PRS, Greve JMD, Santo MA. Muscle strength and body composition in severe obesity. Clinics (Sao Paulo). 2017 May;72(5):272-275. doi: 10.6061/clinics/2017(05)03. — View Citation

Gaines JM, Talbot LA. Isokinetic strength testing in research and practice. Biol Res Nurs. 1999 Jul;1(1):57-64. Review. — View Citation

Gleeson NP, Mercer TH. The utility of isokinetic dynamometry in the assessment of human muscle function. Sports Med. 1996 Jan;21(1):18-34. Review. — View Citation

Handrigan G, Hue O, Simoneau M, Corbeil P, Marceau P, Marceau S, Tremblay A, Teasdale N. Weight loss and muscular strength affect static balance control. Int J Obes (Lond). 2010 May;34(5):936-42. doi: 10.1038/ijo.2009.300. Epub 2010 Jan 26. — View Citation

Hulens M, Vansant G, Claessens AL, Lysens R, Muls E. Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sports. 2003 Apr;13(2):98-105. — View Citation

Hulens M, Vansant G, Lysens R, Claessens AL, Muls E, Brumagne S. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord. 2001 May;25(5):676-81. — View Citation

Hulens M, Vansant G, Lysens R, Claessens AL, Muls E. Assessment of isokinetic muscle strength in women who are obese. J Orthop Sports Phys Ther. 2002 Jul;32(7):347-56. — View Citation

Jaric S. Muscle strength testing: use of normalisation for body size. Sports Med. 2002;32(10):615-31. Review. — View Citation

Jaric S. Role of body size in the relation between muscle strength and movement performance. Exerc Sport Sci Rev. 2003 Jan;31(1):8-12. Review. — View Citation

Karelis AD, Chamberland G, Aubertin-Leheudre M, Duval C; Ecological mobility in Aging and Parkinson (EMAP) group. Validation of a portable bioelectrical impedance analyzer for the assessment of body composition. Appl Physiol Nutr Metab. 2013 Jan;38(1):27-32. doi: 10.1139/apnm-2012-0129. Epub 2013 Jan 1. — View Citation

Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001 Apr;321(4):249-79. Review. — View Citation

Maffiuletti NA, Jubeau M, Munzinger U, Bizzini M, Agosti F, De Col A, Lafortuna CL, Sartorio A. Differences in quadriceps muscle strength and fatigue between lean and obese subjects. Eur J Appl Physiol. 2007 Sep;101(1):51-9. Epub 2007 May 3. — View Citation

Moxley Scarborough D, Krebs DE, Harris BA. Quadriceps muscle strength and dynamic stability in elderly persons. Gait Posture. 1999 Sep;10(1):10-20. — View Citation

Nocera J, Buford TW, Manini TM, Naugle K, Leeuwenburgh C, Pahor M, Perri MG, Anton SD. The impact of behavioral intervention on obesity mediated declines in mobility function: implications for longevity. J Aging Res. 2011;2011:392510. doi: 10.4061/2011/392510. Epub 2011 Oct 16. — View Citation

O'Shea K, Kenny P, Donovan J, Condon F, McElwain JP. Outcomes following quadriceps tendon ruptures. Injury. 2002 Apr;33(3):257-60. — View Citation

Okoro CA, Hootman JM, Strine TW, Balluz LS, Mokdad AH. Disability, arthritis, and body weight among adults 45 years and older. Obes Res. 2004 May;12(5):854-61. — View Citation

Paolillo FR, Milan JC, Bueno Pde G, Paolillo AR, Borghi-Silva A, Parizotto NA, Arena R, Kurachi C, Bagnato VS. Effects of excess body mass on strength and fatigability of quadriceps in postmenopausal women. Menopause. 2012 May;19(5):556-61. doi: 10.1097/gme.0b013e3182364e80. — View Citation

Pereira-Lancha LO, Campos-Ferraz PL, Lancha AH Jr. Obesity: considerations about etiology, metabolism, and the use of experimental models. Diabetes Metab Syndr Obes. 2012;5:75-87. doi: 10.2147/DMSO.S25026. Epub 2012 Apr 10. — View Citation

Rolland Y, Lauwers-Cances V, Pahor M, Fillaux J, Grandjean H, Vellas B. Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional study. Am J Clin Nutr. 2004 Apr;79(4):552-7. — View Citation

Skelton DA, Kennedy J, Rutherford OM. Explosive power and asymmetry in leg muscle function in frequent fallers and non-fallers aged over 65. Age Ageing. 2002 Mar;31(2):119-25. — View Citation

Syed IY, Davis BL. Obesity and osteoarthritis of the knee: hypotheses concerning the relationship between ground reaction forces and quadriceps fatigue in long-duration walking. Med Hypotheses. 2000 Feb;54(2):182-5. — View Citation

Taylor WR, Heller MO, Bergmann G, Duda GN. Tibio-femoral loading during human gait and stair climbing. J Orthop Res. 2004 May;22(3):625-32. — View Citation

Wakeling JM, Liphardt AM, Nigg BM. Muscle activity reduces soft-tissue resonance at heel-strike during walking. J Biomech. 2003 Dec;36(12):1761-9. — View Citation

Wolfson L, Judge J, Whipple R, King M. Strength is a major factor in balance, gait, and the occurrence of falls. J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:64-7. — View Citation

* Note: There are 29 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Muscle strength of the lower limbs Will be evaluated by Biodex Multi-joint System 3 dynamometer that measured the muscle strength of lower limbs by Extension (Ext) and flexion (Flex) torques absolute maximum voluntary contraction (MVC) Newton meter (Nm) 6 months after bariatric surgery
Primary Changes in Muscle strength of the lower limbs Will be evaluated by Biodex Multi-joint System 3 dynamometer that measured the muscle strength of lower limbs by Extension (Ext) and flexion (Flex) torques MVC, Nm 36 months after bariatric surgery
Primary Changes in Body composition Will be evaluated by electrical bioimpedance (InBody 230) that gives automatically data of: Fat Free Mass (FFM) (kg, %), Fat Mass (FM)(kg,%), Fat Free Mass of lower limbs (FFMLL) (kg, %), Fat Mass of lower limbs (FMLL) (kg,%). kilograms (Kg) e percentual (%). 6 months after bariatric surgery
Primary Changes in Body composition Will be evaluated by electrical bioimpedance (InBody 230) that gives automatically data of: FFM (kg, %), FM (kg,%), FFMLL (kg, %), FMLL (kg,%). 36 months after bariatric surgery
Primary Changes in Muscle strength of the lower limbs relative by fat free mass of lower limbs The results of muscle strength of lower limbs by Ext and Flex torques MVC Nm corrected by FFM (kg, %) obtained by assesment bioimpedance 6 months after bariatric surgery
Primary Changes in Muscle strength of the lower limbs relative by fat free mass of lower limbs The results of muscle strength of lower limbs by Ext and Flex torques MVC Nm corrected by FFM (kg, %) obtained by assesment bioimpedance 36 months after bariatric surgery
Primary Correlate muscle strength of the lower limbs with reduction of fat free mass Will be correlated the data of measured the muscle strength of lower limbs Nm with FFM (kg, %) 6 and 36 months after bariatric surgery
Primary Correlate muscle strength of the lower limbs with reduction of fat mass Will be correlated the data of measured the muscle strength of lower limbs Nm with FM (Kg, %) 6 and 36 months after bariatric surgery
Secondary Muscle strength of the lower limbs relative body weight This data is obtained automatically by dynamometer that correct the muscle strength of lower limbs by body weight 6 months and 36 months after bariatric surgery
See also
  Status Clinical Trial Phase
Completed NCT03690752 - Adherence to Walking on an Alter G Anti-Gravity Treadmill N/A
Active, not recruiting NCT02767505 - Bypass Equipoise Sleeve Trial (BEST) N/A
Recruiting NCT05786092 - Impact of Telemonitoring on Metabolic Variables in Severe Obesity N/A
Active, not recruiting NCT03249441 - Compassion-Focused Therapy for People With Severe Obesity. N/A
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT02952963 - Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT02374632 - Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT04165694 - Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision N/A
Completed NCT05409612 - Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients Phase 3
Completed NCT03638895 - Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service N/A
Not yet recruiting NCT05493592 - Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients Returning to Sport? N/A
Completed NCT02823561 - Garcinia Mangostana Extracts in the Management of Weight Loss Phase 4
Completed NCT02340247 - Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass Phase 4
Recruiting NCT02076880 - SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients N/A
Completed NCT04042493 - Connect for Health Pediatric Weight Management Program N/A
Completed NCT05341414 - Trajectories of Resilience and Bariatric Surgery Outcomes
Not yet recruiting NCT06162715 - GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial Phase 2/Phase 3
Recruiting NCT02710786 - Comorbidity After Gastric Bypass
Recruiting NCT02409160 - Sleep and Immune Response in Severe Obese Patients Undergoing Bariatric Surgery. N/A
Completed NCT00623792 - Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery N/A